LeMaitre director Shadan granted dividend rights

LMAT director Martha Shadan received small dividend equivalent right accruals linked to prior equity awards, each economically equal to one common share.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC (symbol: LMAT) is the issuer of record for a Form 4 filing submitted to the SEC. SHADAN MARTHA reported acquisition or exercise transactions in this Form 4 filing.

LEMAITRE VASCULAR INC (LMAT) director Martha Shadan reported several small awards of Dividend Equivalent Rights on September 3, 2026. These derivative rights accrued on previously granted restricted stock unit and performance share unit awards from December 2023, December 2024, and December 2025 and vest proportionately with those awards. Each right is the economic equivalent of one share of common stock, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 4.7443 shares

Grant/Award 5 txns

Insider SHADAN MARTHA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	0.5429	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F2	0.6503	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F3	0.8852	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F4	1.0022	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F5	1.6637	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 26.0982 contracts (Direct)

Footnotes (5)

1. F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend Equivalent Rights award 1: 0.5429 rights Dividend Equivalent Rights award 2: 0.6503 rights Dividend Equivalent Rights award 3: 0.8852 rights +2 more

5 metrics

Dividend Equivalent Rights award 1 0.5429 rights Grant/award acquisition on September 3, 2026, economically equivalent to common stock

Dividend Equivalent Rights award 2 0.6503 rights Grant/award acquisition on September 3, 2026, tied to a performance share unit award granted December 8, 2023

Dividend Equivalent Rights award 3 0.8852 rights Grant/award acquisition on September 3, 2026, tied to a restricted stock unit award granted December 6, 2024

Dividend Equivalent Rights award 4 1.0022 rights Grant/award acquisition on September 3, 2026, tied to a performance share unit award granted December 6, 2024

Dividend Equivalent Rights award 5 1.6637 rights Grant/award acquisition on September 3, 2026, tied to a restricted stock unit award granted December 10, 2025

Key Terms

Dividend Equivalent Rights, restricted stock unit, performance share unit, economic equivalent

4 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award granted"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit financial

"These dividend equivalent rights accrued on a restricted stock unit award granted"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

performance share unit financial

"These dividend equivalent rights accrued on a performance share unit award granted"

A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LMAT director Martha Shadan report in this Form 4?

She reported five small awards of Dividend Equivalent Rights on September 3, 2026. These rights accrued on earlier restricted stock unit and performance share unit awards and are each economically equivalent to one share of LeMaitre Vascular common stock.

How many Dividend Equivalent Rights were granted to the LMAT director on each transaction date?

On September 3, 2026, the director was awarded 0.5429, 0.6503, 0.8852, 1.0022, and 1.6637 Dividend Equivalent Rights, each tied to a separate prior equity award and each economically equivalent to one share of common stock.

What are Dividend Equivalent Rights in the LMAT Form 4 filing?

The filing states that each Dividend Equivalent Right is the economic equivalent of one share of LeMaitre Vascular common stock. They accrued on outstanding restricted stock unit and performance share unit awards and will vest proportionately with those underlying awards.

Were the LMAT Dividend Equivalent Rights linked to specific prior grant dates?

Yes. The Dividend Equivalent Rights accrued on equity awards originally granted on December 8, 2023, December 6, 2024, and December 10, 2025, including both restricted stock unit and performance share unit awards, and they vest in proportion to those grants.

Was a Rule 10b5-1 trading plan involved in this LMAT Form 4?

No. The document-level Rule 10b5-1 checkbox is not affirmed, indicating these reported acquisitions of Dividend Equivalent Rights were not reported as being made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:48 PM Accepted by SEC EDGAR 09/08/2026 - 04:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHADAN MARTHA

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/03/2026		A		0.5429		(1)	(1)	Common Stock	0.5429	$0	5.6103	D
Dividend Equivalent Rights	(2)	09/03/2026		A		0.6503		(2)	(2)	Common Stock	0.6503	$0	5.5195	D
Dividend Equivalent Rights	(3)	09/03/2026		A		0.8852		(3)	(3)	Common Stock	0.8852	$0	5.1836	D
Dividend Equivalent Rights	(4)	09/03/2026		A		1.0022		(4)	(4)	Common Stock	1.0022	$0	5.486	D
Dividend Equivalent Rights	(5)	09/03/2026		A		1.6637		(5)	(5)	Common Stock	1.6637	$0	4.2988	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Douglas G. Bush, Attorney-in-fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)